Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Sage Therapeutics, Inc. (SAGE)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Asset turnover | 0.0 | 0.7 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | -46.7% | 91.4% | -92.1% | -90.2% | -137.8% | -155.8% | | |
| ROIC (including intangibles) | -31.6% | 121.4% | -83.1% | -57.4% | -146.0% | -76.5% | 2553.7% | -6375.6% |
| ROE | -26.7% | 30.1% | -75.0% | -45.6% | -57.4% | -43.5% | -54.5% | -27.7% |
| ROA | -25.3% | 28.9% | -65.3% | -41.3% | -51.5% | -39.6% | -50.1% | -26.1% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 1,070.8 | 0.0 | 0.0 | 0.0 | | | | |
| Days payables outstanding | 6,897.4 | 2,384.5 | 13,930.2 | | | | | |
| Cash conversion cycle | -5,826.6 | -2,384.5 | -13,930.2 | | | | | |
|